Status:
COMPLETED
Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy
Lead Sponsor:
University of Aarhus
Conditions:
Turner Syndrome
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Several studies have demonstrated that Turner Syndrome patients have elevated liver enzymes readily suppressible by a short course of HRT. We wanted to estimated quantitative liver functions in a youn...
Detailed Description
Turner syndrome is due to the absence of a part of or the entire X chromosome in females. Stature is short, and morbidity is increased due to risk of osteoporosis and fractures, type 2 diabetes, ische...
Eligibility Criteria
Inclusion
- Turner syndrome by karyotype
Exclusion
- Thyroid abnormality
- Glucocorticoid treatment
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2000
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00825617
Start Date
October 1 1996
End Date
June 1 2000
Last Update
January 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical department M and Investigational Laboratories
Aarhus C, Jutland, Denmark, 8000